Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

Effort will support a new clinical trial for fibrolamellar carcinoma, a rare cancer that primarily impacts children and young adults GREENWICH, CT, UNITED STATES, April 21, 2025 /EINPresswire.com ...

Fibrolamellar carcinoma (FLC) is a rare, primary liver cancer of young adults without liver disease, distinct from hepatocellular carcinoma (HCC), usually presenting as advanced stage. FLC has been ...

Fibrolamellar Carcinoma (FLC), a rare subtype of HCC, has few options available for treatment. Here we present, for the first time, data showing that HCC-specific AM RF EMF (HCCMF) are effective in ...

Syracuse, N.Y. – A new pathology lab to be built for Upstate Medical University in DeWitt is getting more than $6 million in tax breaks. The Onondaga County Industrial Development Agency on ...

as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). Median overall survival, the primary outcome measure, was 23.7 months in those randomized to ...

The event also marked a monumental milestone for HCC as the first community college in the U.S. and Texas to offer a bachelor’s degree in Artificial Intelligence and Robotics. The conference included ...

Friday morning, HCC President Dr. Alissa Young announced to a group of faculty, staff, and stakeholders the $400,000 gift from Diane and Steve Thomas. Dr. Young adds the professional and technical ...

Patients who used statins had a reduced risk for HCC, hepatic decompensation and fibrosis progression. Lipophilic statin use and longer duration of exposure were associated with even greater ...